Bayer (1BAYN) Financial Statements
Bayer Financial Overview
Bayer's market cap is currently $49.69B. The company's EPS TTM is $-1.76; its P/E ratio is -28.74; and it has a dividend yield of 0.22%. Bayer is scheduled to report earnings on November 3, 2026, and the estimated EPS forecast is $0.39. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 45.58B | $ 46.61B | $ 47.64B | $ 50.74B | $ 44.08B |
| Gross Profit | $ 26.98B | $ 25.34B | $ 27.89B | $ 30.87B | $ 27.27B |
| Operating Income | $ 6.95B | $ 4.48B | $ 8.41B | $ 8.24B | $ 7.93B |
| EBITDA | $ 2.65B | $ 3.67B | $ 4.05B | $ 10.29B | $ 7.02B |
| Net Income | $ -3.62B | $ -2.55B | $ -2.94B | $ 4.15B | $ 1.00B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.86B | $ 8.09B | $ 10.59B | $ 10.15B | $ 7.74B |
| Total Assets | $ 110.61B | $ 110.85B | $ 116.26B | $ 124.88B | $ 120.24B |
| Total Debt | $ 37.44B | $ 40.74B | $ 44.79B | $ 41.65B | $ 39.53B |
| Net Debt | $ 30.77B | $ 34.55B | $ 38.88B | $ 36.48B | $ 34.97B |
| Total Liabilities | $ 84.54B | $ 78.81B | $ 83.18B | $ 85.95B | $ 87.07B |
| Stockholders' Equity | $ 25.95B | $ 31.91B | $ 32.93B | $ 38.77B | $ 33.02B |
| Cash Flow | |||||
| Free Cash Flow | $ 2.08B | $ 4.59B | $ 2.37B | $ 4.14B | $ 2.48B |
| Operating Cash Flow | $ 4.57B | $ 7.37B | $ 5.12B | $ 7.09B | $ 5.09B |
| Investing Cash Flow | $ -1.61B | $ 164.00M | $ -4.01B | $ -2.38B | $ 855.00M |
| Financing Cash Flow | $ -2.19B | $ -7.18B | $ -679.00M | $ -4.22B | $ -5.64B |
Currency in EUR